Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
47.00    -1.00 (-2.08%)
Bid:
46.50
Ask:
47.50
Spread: 1.00 (2.151%)
Market Cap: £90.17m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Directorate Change

19 Sep 2013 07:00

RNS Number : 3675O
Iofina PLC
19 September 2013
 



19 September 2013

 

Iofina plc

("Iofina" or the "Group")

(LSE AIM: IOF)

CEO Appointment

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to announce the appointment of George Everett Lantz, who will be joining the PLC Board as Chief Executive Officer with immediate effect. As previously stated, Dr. Chris Fay will return to his previous position of Non-Executive Chairman.

 

Mr Lantz (62) joins the Board with a demonstrable track record spanning over 30 years in industry. He was most recently a consultant to the Group division, Iofina Resources, Inc. During his time with Iofina Resources, Inc. Mr Lantz helped achieve a daily record iodine production. Mr Lantz was also responsible for financial controls, business development, and managed the build-out of the Group's IO#3, and the on-going construction of IO#4, IO#5, and IO#6, iodine extraction plants based on Iofina's WET® IOsorb™ technology.

 

Prior to joining Iofina Resources, Inc., Mr Lantz held the positions of Founder and Vice President at Voyant Technologies; Vice President at Polycom; Vice President of Frontier ConferTech; Corporate New Business Manager ROLM (a Siemens Company); Sales Engineer at IBM Corporation; and Design Engineer with Texaco, Inc. Mr Lantz has a Bachelor of Science in Civil Engineering and a Master of Science in Industrial Management from the University of Wyoming, USA. Mr Lantz owns 26,433 ordinary shares in Iofina, representing 0.02 per cent. of the issued share capital.

 

The enlarged Group Board now comprises four Non-Executive Directors and three Executive Directors.

 

Commenting on the appointment Dr. Chris Fay, Non-Executive Chairman said: We are delighted to welcome George to the Board at a very exciting time of becoming a preeminent fast growing iodine producer. George is extremely well prepared to head our experienced management team and drive the Group forward into its next stage of growth."

 

There is no further information required to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules.

For further information, please contact:

 

George Lantz, CEO

Iofina plc

Tel: +44(0)20 3006 3135

www.iofina.com

 

Ben Colegrave/Chris Sim/ James Rudd

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

 

About Iofina

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUMABUPWGMR
Date   Source Headline
24th May 20174:40 pmRNSSecond Price Monitoring Extn
24th May 20174:35 pmRNSPrice Monitoring Extension
24th May 201712:07 pmRNSSecond Price Monitoring Extn
24th May 201712:02 pmRNSPrice Monitoring Extension
19th May 20177:00 amRNSFinal Results and Notice of AGM
3rd May 20174:41 pmRNSSecond Price Monitoring Extn
3rd May 20174:35 pmRNSPrice Monitoring Extension
25th Apr 20174:40 pmRNSSecond Price Monitoring Extn
25th Apr 20174:35 pmRNSPrice Monitoring Extension
11th Apr 20177:00 amRNSTrading Update
3rd Apr 20177:00 amRNSProduction update
14th Feb 20174:35 pmRNSPrice Monitoring Extension
13th Jan 20177:00 amRNSCorporate Update
13th Dec 20164:35 pmRNSPrice Monitoring Extension
12th Dec 20167:00 amRNSCorporate update
2nd Dec 20167:00 amRNSChange of Registered Office
4th Nov 20167:00 amRNSDirectorate Change
13th Oct 20167:00 amRNSTrading Update
30th Sep 20167:00 amRNSCompletion of Debt Restructure
30th Sep 20167:00 amRNSInterim Results
12th Sep 20164:35 pmRNSPrice Monitoring Extension
17th Aug 20164:40 pmRNSSecond Price Monitoring Extn
17th Aug 20164:35 pmRNSPrice Monitoring Extension
11th Aug 20161:33 pmRNSWater Depot Permit Update
25th Jul 20164:40 pmRNSSecond Price Monitoring Extn
25th Jul 20164:35 pmRNSPrice Monitoring Extension
11th Jul 20167:00 amRNSCorporate and Production Update
7th Jun 201611:37 amRNSResult of AGM
7th Jun 20167:00 amRNSRestructure of Debt
9th May 20167:00 amRNSFinal Results and Notice of AGM
11th Apr 20167:00 amRNSMarket update
15th Feb 20167:00 amRNSDirectorate Change
18th Jan 20167:00 amRNSCorporate Update
14th Dec 20157:00 amRNSTrading Update
23rd Nov 20157:00 amRNSBrine Supply Update
28th Oct 20157:00 amRNSAppointment of CFO
15th Oct 20159:00 amRNSIofina becomes founding member of the WIA
9th Oct 20157:00 amRNSProduction and Corporate Update
5th Oct 20151:59 pmRNSChange of Registered Office
29th Sep 20157:00 amRNSInterim Results
14th Jul 20157:00 amRNSCorporate & Trading Update
22nd Jun 20155:41 pmRNSHolding(s) in Company
19th Jun 201512:05 pmRNSResult of AGM
16th Jun 20157:00 amRNSProduction Update
5th Jun 20157:00 amRNSWater Depot Permit Update
27th May 20157:00 amRNSFinal Results and Notice of AGM
11th May 20157:00 amRNSAnnouncement of Final Results
22nd Apr 20157:00 amRNSChange of Adviser
15th Apr 20157:00 amRNSProduction Update & Notice of Results
13th Jan 20157:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.